Skip to main content
. 2021 Aug 23;14(11):103393. doi: 10.1016/j.arabjc.2021.103393

Table 3.

Active site residues of each ligand within 5 Å.

Compounds Residues within 5 Å
NO3 Thr24, Thr25, Thr26, Leu27, His41, Met49, Tyr54, Phe140, Leu141, Asn142, Gly143, Ser144, Cys145, His163, His164, Met165, Glu166, Leu167, Pro168, His172, Asp187, Arg188, Gln189, Thr190, Ala191, Gln192
CHOLEST-5-EN-3-OL (3.BETA.)- Thr 24, Thr25, Thr26, Leu27, His41, Val42, Met49, Leu141, Asn142, Gly143, Ser144, Cys145, His163, His164, Met165, Glu166, Leu167, Pro168, Phe185, Val186, Asp187, Arg188, Gln189, Thr190, Ala191, Gln192, Ala193
1–2 Tetradecandiol Thr24, Thr25, Thr26, Leu27, His41, Val42, Cys44, Asp48, Met49, Leu50, Pro51, Tyr54, Asn142, Gly143, Ser144, Cys145, His164, Met165, Glu166, Val186, Asp187, Arg188, Gln189
E,E,Z-1,3,12-Nonadecatriene-5,14-diol Thr24, Thr25, Thr26, Leu27, His41, Val42, Met49, Gly143, Cys145, Tyr154, His164, Met165, Glu166, Leu167, Pro168, Val186, Asp187, Arg188, Gln189
Remdesivir Thr24, Thr25, Thr26, Leu27, His41, Met49, Leu50, Phe140, Leu141, Asn142, Gly143, Ser144, Cys145, Gly146, His163, His164, Met165, Glu166, Leu167, Pro168, His172, Gln189, Thr190, Ala191